Biote reported a 4.4% increase in revenue to $46.8 million, driven by a 6.6% increase in procedure revenue. The company's gross profit margin increased by approximately 240 basis points to 71.4%. Net loss was $(5.8) million, with a loss per share of $(0.06). Adjusted EBITDA increased by 8.0% to $14.2 million.
Revenue increased by 4.4% to $46.8 million.
Procedure revenue increased by 6.6% to $37.4 million.
Gross profit margin increased by approximately 240 basis points to 71.4%.
Adjusted EBITDA increased by 8.0% to $14.2 million.
The company reaffirms its 2024 financial guidance, expecting stronger revenue growth in the second half of the year.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance